Article
The FDA has approved the Prolieve Thermodilatation system for the treatment of BPH symptoms.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Pivotal data for lumasiran in PH1 published in NEJM
Nedosiran explored in primary hyperoxaluria type 3
Enrollment completed in pivotal trial of nedosiran for hyperoxaluria
FDA approves androgen inhibitor for metastatic PCa
Blood test could guide treatment for kidney cancer
BCG for bladder cancer in short supply
Survey data shows lack of awareness on prostate, testicular cancer
FDA issues complete response letter for 89Zr-DFO-girentuximab in ccRCC
Decipher test is predictive of chemotherapy benefit in metastatic prostate cancer
AI and prostate cancer: Balancing hope and caution